Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.78 ($0.03), with a volume of 455149 shares. The stock had previously closed at GBX 2.60 ($0.03).
Proteome Sciences Stock Performance
The firm’s fifty day moving average is GBX 2.81 and its 200-day moving average is GBX 3.30. The stock has a market capitalization of £8.12 million, a PE ratio of -275.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- How to Most Effectively Use the MarketBeat Earnings Screener
- Tesla Investors Continue to Profit From the Trump Trade
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Where Do I Find 52-Week Highs and Lows?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
